3.20.2 html 75 195 1 false 9 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://biolinerx.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION (UNAUDITED) Sheet http://biolinerx.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION (UNAUDITED) Statements 2 false false R3.htm 00000003 - Statement - CONDENSED CONSOLIDATED INTERIM STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) Sheet http://biolinerx.com/role/CondensedConsolidatedInterimStatementsOfComprehensiveLoss CONDENSED CONSOLIDATED INTERIM STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) Statements 3 false false R4.htm 00000004 - Statement - CONDENSED INTERIM STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) Sheet http://biolinerx.com/role/CondensedInterimStatementsOfChangesInEquity CONDENSED INTERIM STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) Statements 4 false false R5.htm 00000005 - Statement - CONDENSED CONSOLIDATED INTERIM CASH FLOW STATEMENTS (UNAUDITED) Sheet http://biolinerx.com/role/CondensedConsolidatedInterimCashFlowStatements CONDENSED CONSOLIDATED INTERIM CASH FLOW STATEMENTS (UNAUDITED) Statements 5 false false R6.htm 00000006 - Disclosure - GENERAL INFORMATION Sheet http://biolinerx.com/role/GeneralInformation GENERAL INFORMATION Notes 6 false false R7.htm 00000007 - Disclosure - BASIS OF PREPARATION Sheet http://biolinerx.com/role/BasisOfPreparation BASIS OF PREPARATION Notes 7 false false R8.htm 00000008 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://biolinerx.com/role/SignificantAccountingPolicies SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - AT-THE-MARKET (ATM) SALES AGREEMENT WITH BTIG Sheet http://biolinerx.com/role/At-the-marketAtmSalesAgreementWithBtig AT-THE-MARKET (ATM) SALES AGREEMENT WITH BTIG Notes 9 false false R10.htm 00000010 - Disclosure - FINANCINGS Sheet http://biolinerx.com/role/Financings FINANCINGS Notes 10 false false R11.htm 00000011 - Disclosure - SHAREHOLDERS' EQUITY Sheet http://biolinerx.com/role/ShareholdersEquity SHAREHOLDERS' EQUITY Notes 11 false false R12.htm 00000013 - Disclosure - SHAREHOLDERS' EQUITY (Tables) Sheet http://biolinerx.com/role/ShareholdersEquityTables SHAREHOLDERS' EQUITY (Tables) Tables http://biolinerx.com/role/ShareholdersEquity 12 false false R13.htm 00000014 - Disclosure - GENERAL INFORMATION (Narrative) (Details) Sheet http://biolinerx.com/role/GeneralInformationNarrativeDetails GENERAL INFORMATION (Narrative) (Details) Details http://biolinerx.com/role/GeneralInformation 13 false false R14.htm 00000015 - Disclosure - AT-THE-MARKET (ATM) SALES AGREEMENT WITH BTIG (Details) Sheet http://biolinerx.com/role/At-the-marketAtmSalesAgreementWithBtigDetails AT-THE-MARKET (ATM) SALES AGREEMENT WITH BTIG (Details) Details http://biolinerx.com/role/At-the-marketAtmSalesAgreementWithBtig 14 false false R15.htm 00000016 - Disclosure - FINANCINGS (Narrative) (Details) Sheet http://biolinerx.com/role/FinancingsNarrativeDetails FINANCINGS (Narrative) (Details) Details http://biolinerx.com/role/Financings 15 false false R16.htm 00000017 - Disclosure - SHAREHOLDERS' EQUITY (Schedule of Share Capital) (Details) Sheet http://biolinerx.com/role/ShareholdersEquityScheduleOfShareCapitalDetails SHAREHOLDERS' EQUITY (Schedule of Share Capital) (Details) Details http://biolinerx.com/role/ShareholdersEquityTables 16 false false All Reports Book All Reports blrx-20200630.xml blrx-20200630.xsd blrx-20200630_cal.xml blrx-20200630_def.xml blrx-20200630_lab.xml blrx-20200630_pre.xml http://fasb.org/srt/2019-01-31 http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full http://xbrl.sec.gov/dei/2019-01-31 http://xbrl.sec.gov/currency/2019-01-31 true true